Community-acquired skin and soft-tissue infections in people who inject drugs

Link to article at PubMed

Curr Opin Infect Dis. 2023 Jan 26. doi: 10.1097/QCO.0000000000000902. Online ahead of print.


PURPOSE OF REVIEW: The aim of this review is to discuss the latest evidence of the epidemiology, microbiology, risk factors, diagnosis and management of community-acquired skin and soft tissue infections (SSTIs) in people who inject drug (PWID).

RECENT FINDINGS: SSTIs are common complications in PWID and a major cause of morbidity and mortality. Infections can range from uncomplicated cellulitis, to abscesses, deep tissue necrosis and necrotizing fasciitis. They are predominantly caused by Gram-positive pathogens in particular Staphylococcus aureus and Streptococcus species; however, toxin-producing organisms such as Clostridium botulism or Clostridium tetani should be considered. The pathogenesis of SSTI in the setting of intravenous drug use (IDU) is different from non-IDU related SSTI, and management often requires surgical interventions in addition to adjunctive antibiotics. Harm reduction strategies and education about safe practices should be implemented to prevent morbidity and mortality as well as healthcare burden of SSTI in PWID.

SUMMARY: Prompt diagnosis and proper medical and surgical management of SSTI will improve outcomes in PWID.

PMID:36718912 | DOI:10.1097/QCO.0000000000000902

Leave a Reply

Your email address will not be published. Required fields are marked *